James R. Kasinger - Net Worth and Insider Trading
James R. Kasinger Net Worth
The estimated net worth of James R. Kasinger is at least $5 Million dollars as of 2026-09-21. James R. Kasinger is the General Counsel and Secretary of CRISPR Therapeutics AG and owns about 94,308 shares of CRISPR Therapeutics AG (CRSP) stock worth over $5 Million. Details can be seen in James R. Kasinger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James R. Kasinger has not made any transactions after 2026-03-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James R. Kasinger
James R. Kasinger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James R. Kasinger owns 1 companies in total, including CRISPR Therapeutics AG (CRSP) .
Click here to see the complete history of James R. Kasinger’s form 4 insider trades.
Insider Ownership Summary of James R. Kasinger
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2026-03-23 | General Counsel and Secretary |
James R. Kasinger Latest Holdings Summary
James R. Kasinger currently owns a total of 1 stock. James R. Kasinger owns 94,308 shares of CRISPR Therapeutics AG (CRSP) as of March 23, 2026, with a value of $5 Million.
Latest Holdings of James R. Kasinger
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2026-03-23 | 94,308 | 56.56 | 5,334,060 |
Holding Weightings of James R. Kasinger
James R. Kasinger Form 4 Trading Tracker
According to the SEC Form 4 filings, James R. Kasinger has made a total of 11 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in CRISPR Therapeutics AG is the sale of 3,182 shares on March 23, 2026, which brought James R. Kasinger around $148,854.
Insider Trading History of James R. Kasinger
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
James R. Kasinger Trading Performance
James R. Kasinger Ownership Network
Ownership Network List of James R. Kasinger
Ownership Network Relation of James R. Kasinger

James R. Kasinger Owned Company Details
What does CRISPR Therapeutics AG do?
Who are the key executives at CRISPR Therapeutics AG?
James R. Kasinger is the General Counsel and Secretary of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include Chief Medical Officer Naimish Patel , Chief Financial Officer Raju Prasad , and Chief Business Officer Samarth Kulkarni .
CRISPR Therapeutics AG (CRSP) Insider Trades Summary
Over the past 18 months, James R. Kasinger made 5 insider transaction in CRISPR Therapeutics AG (CRSP) with a net sale of 12,620. Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 195,352 shares made by Samarth Kulkarni , a net sale of 78,249 shares made by Raju Prasad , and a net sale of 9,360 shares made by Naimish Patel .
In summary, during the past 3 months, insiders sold 0 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 297,089 shares of CRISPR Therapeutics AG (CRSP) were sold and 1,011,320 shares were bought by its insiders, resulting in a net purchase of 714,231 shares.
CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.
CRISPR Therapeutics AG Insider Transactions
James R. Kasinger Mailing Address
Above is the net worth, insider trading, and ownership report for James R. Kasinger. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, James R. Kasinger's mailing address is: Cambridge Ma 02139.